3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
6
Neoplasms
1
Mesothelioma, Malignant
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Interventions
pembrolizumab
1
obinutuzumab
1
acalabrutinib
1
Rituximab
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphatic Diseases
×
Brentuximab Vedotin
×
30 days
×
Clear all
No trials found.